The economic impact of a bioterrorist attack: are prevention and postattack intervention programs justifiable?

Understanding and quantifying the impact of a bioterrorist attack are essential in developing public health preparedness for such an attack. We constructed a model that compares the impact of three classic agents of biologic warfare (Bacillus anthracis, Brucella melitensis, and Francisella tularensis) when released as aerosols in the suburb of a major city. The model shows that the economic impact of a bioterrorist attack can range from an estimated $477.7 million per 100,000 persons exposed (brucellosis scenario) to $26.2 billion per 100,000 persons exposed (anthrax scenario). Rapid implementation of a postattack prophylaxis program is the single most important means of reducing these losses. By using an insurance analogy, our model provides economic justification for preparedness measures.

[1]  P S Schenck,et al.  CONTROL OF COMMUNICABLE DISEASES. , 1914, American journal of public health.

[2]  S. Miller,et al.  Control of communicable diseases. , 1949, The Journal-lancet.

[3]  I. L. Bennett,et al.  Brucellosis. I. Laboratory-acquired acute infection. , 1959, A.M.A. archives of internal medicine.

[4]  H. Wilson,et al.  Tularemia vaccine study. II. Respiratory challenge. , 1961, Archives of internal medicine.

[5]  F. McCrumb,et al.  AEROSOL INFECTION OF MAN WITH PASTEURELLA TULARENSIS. , 1961, Bacteriological reviews.

[6]  A. Hogge,et al.  Antibiotic prophylaxis and therapy of airborne tularemia. , 1966, Bacteriological reviews.

[7]  Perspective , 1974 .

[8]  D. Commerce Statistical abstract of the United States , 1978 .

[9]  A. Kaufmann,et al.  AIRBORNE SPREAD OF BRUCELLOSIS , 1980, Annals of the New York Academy of Sciences.

[10]  J. Canela-Soler,et al.  An outbreak of Brucella melitensis infection by airborne transmission among laboratory workers. , 1987, American journal of public health.

[11]  A. Hallam The competitive firm's response to risk , 1987 .

[12]  M. Zervos,et al.  Outbreak of Brucella melitensis among microbiology laboratory workers in a community hospital. , 1989, Journal of clinical microbiology.

[13]  D H Walker,et al.  Pathology of inhalational anthrax in 42 cases from the Sverdlovsk outbreak of 1979. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[14]  J. Ezzell,et al.  Postexposure prophylaxis against experimental inhalation anthrax. , 1993, The Journal of infectious diseases.

[15]  J. Feldman,et al.  Health, United States, 1993 , 1994 .

[16]  M. Hugh-jones,et al.  The Sverdlovsk anthrax outbreak of 1979. , 1994, Science.

[17]  J. Solera,et al.  Doxycycline-rifampin versus doxycycline-streptomycin in treatment of human brucellosis due to Brucella melitensis. The GECMEI Group. Grupo de Estudio de Castilla-la Mancha de Enfermedades Infecciosas , 1995, Antimicrobial agents and chemotherapy.

[18]  M. Gold Cost-effectiveness in health and medicine , 2016 .

[19]  L. Cole,et al.  The specter of biological weapons. , 1996, Scientific American.

[20]  C. Roelofs Prevention effectiveness: A guide to decision analysis and economic evaluation , 1997 .

[21]  Shane Marley,et al.  Control of Communicable Diseases Manual , 1997, Annals of Internal Medicine.